Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Fundamental & Clinical Pharmacology

• Publication date

  2000-03-04

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1472-8206.2000.tb00395.xPMID 10796054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review: Amino acid domains involved in constitutive activation of G-protein-coupled receptors

  2007cited by this paper
• Antagonist-induced μ-opioid receptor up-regulation decreases G-protein receptor kinase-2 and dynamin-2 abundance in mouse spinal cord

  2002cited by this paper
• G protein antagonists.

  1999cited by this paper
• Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.

  1999cited by this paper
• SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor.

  1999cited by this paper
• 3-Isobutyl-1-methylxanthine inhibits basal mu-opioid receptor phosphorylation and reverses acute morphine tolerance and dependence in mice.

  1999cited by this paper
• Ligand efficacy and affinity in an interacting 7TM receptor model.

  1999cited by this paper
• Inverse Agonists and Serotonergic Transmission: From Recombinant, Human Serotonin (5-HT)1B Receptors to G-Protein Coupling and Function in Corticolimbic Structures in vivo

  1999cited by this paper
• Inverse agonist properties of dopaminergic antagonists at the D(1A) dopamine receptor: uncoupling of the D(1A) dopamine receptor from G(s) protein.

  1999cited by this paper
• Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity.

  1999cited by this paper
• Agonism and inverse agonism at dopamine D2-like receptors.

  1999cited by this paper
• Inverse Agonism and Neutral Antagonism at α1a- and α1b-Adrenergic Receptor Subtypes

  1999cited by this paper
• G‐protein coupled receptor kinases as modulators of G‐protein signalling

  1999cited by this paper
• (2S,3R)TMT-L-Tic-OH is a potent inverse agonist at the human delta-opioid receptor.

  1999cited by this paper
• Inverse agonist activities of beta-adrenoceptor antagonists in rat myocardium.

  1999cited by this paper
• Structural determinants of the partial agonist‐inverse agonist properties of 6′‐azidohex‐2′‐yne‐Δ8‐tetrahydrocannabinol at cannabinoid receptors

  1999cited by this paper
• Inhibition of GTPase activity of Gi proteins and decreased agonist affinity at M2 muscarinic acetylcholine receptors by spermine and methoctramine

  1999cited by this paper
• Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists.

  1999cited by this paper
• Constitutive β2‐adrenergic signalling enhances sarcoplasmic reticulum Ca2+ cycling to augment contraction in mouse heart

  1999cited by this paper
• Inverse agonist activity of pirenzepine at M2 muscarinic acetylcholine receptors

  1999cited by this paper
• SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.

  1999cited by this paper
• Modulation of basal intracellular calcium by inverse agonists and phorbol myristate acetate in rat‐1 fibroblasts stably expressing α1d‐adrenoceptors

  1999cited by this paper
• Treatment with inverse agonists enhances baseline atrial contractility in transgenic mice with chronic beta2‐adrenoceptor activation

  1999cited by this paper
• Spontaneous Human B2 Bradykinin Receptor Activity Determines the Action of Partial Agonists as Agonists or Inverse Agonists

  1999cited by this paper
• Partial agonists and G protein-coupled receptor desensitization.

  1999cited by this paper
• Constitutive activity of the δ‐opioid receptor expressed in C6 glioma cells: identification of non‐peptide δ‐inverse agonists

  1999cited by this paper
• (2S, 3R)TMT-L-Tic-OH is a potent inverse agonist at the human δ-opioid receptor

  1999cited by this paper
• Inverse agonist activities of β‐adrenoceptor antagonists in rat myocardium

  1999cited by this paper
• Ligand efficacy and affinity in an interacting 7TM receptor model

  1999cited by this paper
• Inverse agonism and neutral antagonism at alpha(1a)- and alpha(1b)-adrenergic receptor subtypes.

  1999cited by this paper
• The role of receptor kinases and arrestins in G protein-coupled receptor regulation.

  1998cited by this paper
• G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

  1998cited by this paper
• The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange

  1998cited by this paper
• Domain swapping in G-protein coupled receptor dimers.

  1998cited by this paper
• Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and of the effects of mutating receptors

  1998cited by this paper
• Structural and functional aspects of G protein-coupled receptor oligomerization.

  1998cited by this paper
• Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors

  1998cited by this paper
• The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities

  1998cited by this paper
• Drugs interacting with G protein α subunits: selectivity and perspectives

  1998cited by this paper
• Gsalpha-selective G protein antagonists.

  1998cited by this paper
• G protein-coupled receptor kinases.

  1998cited by this paper
• The 5‐HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5‐HT4(c) receptor

  1998cited by this paper
• Agonist-independent regulation of constitutively active G-protein-coupled receptors.

  1998cited by this paper
• Mammalian RGS Proteins: Barbarians at the Gate*

  1998cited by this paper
• Drugs interacting with G protein alpha subunits: selectivity and perspectives.

  1998cited by this paper
• Functional characterisation of the human cloned 5‐HT7 receptor (long form); antagonist profile of SB‐258719

  1998cited by this paper
• Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells.

  1998cited by this paper
• The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange.

  1998cited by this paper
• Interactions of ligands with active and inactive conformations of the dopamine D2 receptor.

  1998cited by this paper
• Pharmacological analysis of G‐protein activation mediated by guinea‐pig recombinant 5‐HT1B receptors in C6‐glial cells: similarities with the human 5‐HT1B receptor

  1998cited by this paper
• A MODIFICATION OF RECEPTOR THEORY

  1997cited by this paper
• A three-state receptor model of agonist action.

  1997cited by this paper
• Up-regulation of the levels of expression and function of a constitutively active mutant of the hamster alpha1B-adrenoceptor by ligands that act as inverse agonists.

  1997cited by this paper
• Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation

  1997cited by this paper
• Inhibition of the constitutive activity of human 5‐HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635

  1997cited by this paper
• Protean Agonists

  1997cited by this paper
• Agonist-specific receptor conformations.

  1997cited by this paper
• Agonist-specific receptor conformations: Ligands create bias in already complex systems

  1997cited by this paper
• Inverse agonism and the regulation of receptor number.

  1997cited by this paper
• Agonist Efficacy and Aliosteric Models of Receptor Action a

  1997cited by this paper
• Defects in G protein-coupled signal transduction in human disease.

  1996cited by this paper
• THE CUBIC TERNARY COMPLEX RECEPTOR-OCCUPANCY MODEL. II. UNDERSTANDING APPARENT AFFINITY

  1996cited by this paper
• Phosducin is a ubiquitous G-protein regulator.

  1996cited by this paper
• Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors.

  1996cited by this paper
• The cubic ternary complex receptor-occupancy model. III. resurrecting efficacy.

  1996cited by this paper
• Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors.

  1996cited by this paper
• Inverse agonist-induced up-regulation of the human beta2-adrenoceptor in transfected neuroblastoma X glioma hybrid cells.

  1996cited by this paper
• Further evidence that naloxone acts as an inverse opiate agonist: implications for drug dependence and withdrawal.

  1996cited by this paper
• M2-muscarinic receptors: how does ligand binding affinity relate to intrinsic activity?

  1996cited by this paper
• Inverse Agonism at Dopamine D2 Receptors

  1996cited by this paper
• Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division.

  1996cited by this paper
• The Cubic Ternary Complex ReceptorOccupancy Model I. Model Description

  1996cited by this paper
• A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: evidence using chlordiazepoxide as a negative antagonist.

  1995cited by this paper
• Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.

  1995cited by this paper
• Direct and indirect receptor‐independent G‐protein activation by cationic‐amphiphilic substances. Studies with mast cells, HL‐60 human leukemic cells and purified G‐proteins

  1995cited by this paper
• Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity.

  1995cited by this paper
• Signalling and regulation of the alpha 1B-adrenergic receptor.

  1995cited by this paper
• Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

  1995cited by this paper
• GAIP, a protein that specifically interacts with the trimeric G protein G alpha i3, is a member of a protein family with a highly conserved core domain.

  1995cited by this paper
• Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor

  1995cited by this paper
• Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands.

  1994cited by this paper
• Precoupling of alpha-2B adrenergic receptors and G-proteins in transfected PC-12 cell membranes: influence of pertussis toxin and a lysine-directed cross-linker.

  1994cited by this paper
• A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated.

  1994cited by this paper
• Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor.

  1994cited by this paper
• Inverse agonist activity of beta-adrenergic antagonists.

  1994cited by this paper
• Agonist‐independent effects of muscarinic antagonists on Ca2+ and K+ currents in frog and rat cardiac cells.

  1993cited by this paper
• Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins.

  1993cited by this paper
• Mechanisms of multifunctional signalling by G protein-linked receptors.

  1993cited by this paper
• A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model.

  1993cited by this paper
• Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand.

  1992cited by this paper
• Phosducin is a protein kinase A-regulated G-protein regulator

  1992cited by this paper
• G protein antagonists. A novel hydrophobic peptide competes with receptor for G protein binding.

  1992cited by this paper
• Reverse intrinsic activity of antagonists on G protein-coupled receptors.

  1992cited by this paper
• G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity.

  1991cited by this paper
• Exocytosis in mast cells by basic secretagogues: evidence for direct activation of GTP-binding proteins

  1990cited by this paper
• G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides.

  1990cited by this paper
• Direct activation of GTP‐binding regulatory proteins (G‐proteins) by substance P and compound 48/80

  1990cited by this paper
• Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins.

  1989cited by this paper
• Activation of rat peritoneal mast cells by substance P and mastoparan.

  1989cited by this paper
• Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.

  1988cited by this paper

• Functional Characterization of the Internal Symmetry of MRAP2 Antiparallel Homodimer

  2021cites this paper
• Structural and functional interactions of platelet thrombin and ADP receptors

  2015cites this paper
• The Physical Association of the P 2 Y 12 Receptor with PAR 4 Regulates Arrestin-Mediated Akt Activation s

  2014cites this paper
• The Physical Association of the P2Y12 Receptor with PAR4 Regulates Arrestin-Mediated Akt Activation

  2014cites this paper
• Histaminergic regulation of appetite

  2010cites this paper
• Agonist-Selective Coupling of G Protein-Coupled Receptors

  2009cites this paper
• Pharmacological Analysis of Human D1 and D2 Dopamine Receptor Missense Variants

  2008cites this paper
• Drugs and their molecular targets: an updated overview

  2008cites this paper
• Molecular Drug Targets

  2008cites this paper
• Modulations pharmacologiques des systmes dopaminergiques : des neuroleptiques laripiprazole

  2007cites this paper
• CHANGES IN THE IN VITRO PHARMACODYNAMIC PROPERTIES OF METOPROLOL IN ATRIA ISOLATED FROM SPONTANEOUSLY HYPERTENSIVE RATS

  2007cites this paper
• Conformational state of human cardiac 5-HT(4(g)) receptors influences the functional effects of polyclonal anti-5-HT(4) receptor antibodies.

  2007cites this paper
• How drugs act: general principles

  2007cites this paper
• Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system.

  2006cites this paper
• Pharmacological characterization and autoradiographic distribution of alpha2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain.

  2006cites this paper
• Cellular and molecular biology of orphan G protein-coupled receptors.

  2006cites this paper
• Intrinsic Efficacy of Antipsychotics at Human D2, D3, and D4 Dopamine Receptors: Identification of the Clozapine Metabolite N-Desmethylclozapine as a D2/D3 Partial Agonist

  2005cites this paper
• Modulation of the M2 Muscarinic Acetylcholine Receptor Activity with Monoclonal Anti-M2 Receptor Antibody Fragments*

  2004cites this paper
• Implication du récepteur 5-HT4 cardiaque humain dans la fibrillation auriculaire : rôle d’auto-anticorps dirigés contre ce récepteur ?

  2004cites this paper
• Exploring agonist dependency of receptor-G protein-coupling and constitutive activity at muscarinic acetylcholine receptors

  2004influential citation
• An algebra of dimerization and its implications for G-protein coupled receptor signaling.

  2004cites this paper
• The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors.

  2003cites this paper
• Inverse agonism gains weight.

  2003cites this paper
• 3 – MEASUREMENT AND EXPRESSION OF DRUG EFFECTS

  2003cites this paper
• scFv Single Chain Antibody Variable Fragment as Inverse Agonist of the β2-Adrenergic Receptor*

  2003cites this paper
• Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors.

  2003cites this paper
• Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective.

  2003cites this paper
• Enhanced stability of wild-type and constitutively active α2A-adrenoceptors by ligands with agonist, silent and inverse agonist properties

  2002cites this paper
• Heterotrimeric G proteins control diverse pathways of transmembrane signaling, a base for drug discovery.

  2002cites this paper
• Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors

  2002cites this paper
• Bucindolol Displays Intrinsic Sympathomimetic Activity in Human Myocardium

  2002cites this paper
• Mechanisms of inverse agonism at G-protein-coupled receptors.

  2002cites this paper
• Ligand modulation of [35S]GTPgammaS binding at human alpha(2A), alpha(2B) and alpha(2C) adrenoceptors.

  2002cites this paper
• Ligand modulation of [ 35S]GTP?S binding at human a 2A, a 2B and a 2C adrenoceptors

  2002cites this paper
• Dexras1/AGS-1 Inhibits Signal Transduction from the Gi-coupled Formyl Peptide Receptor to Erk-1/2 MAP Kinases*

  2002cites this paper
• Strategies to identify ligands for orphan G-protein-coupled receptors.

  2001cites this paper
• Differential signalling of both wild-type and Thr(343)Arg dopamine D(2short) receptor by partial agonists in a G-protein-dependent manner.

  2001cites this paper
• Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.

  2001cites this paper
• Real‐time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation state

  2001cites this paper
• Differential modulation by GTPγS of agonist and inverse agonist binding to h5‐HT1A receptors revealed by [3H]‐WAY100,635

  2001cites this paper
• [Control of bronchial contractility, regulation of receptor activity and expression].

  2000cites this paper
• Partial to complete antagonism by putative antagonists at the wild‐type α2C‐adrenoceptor based on kinetic analyses of agonist : antagonist interactions

  2000cites this paper